The ProHeart debate.
Curry-Galvin
Elizabeth
E
D000818:Animals; D000969:Antinematodal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004184:Dirofilariasis / Q000517:prevention & control*; D004283:Dog Diseases / Q000517:prevention & control*; D004285:Dogs; D004335:Drug and Narcotic Control; D018942:Macrolides / Q000009:adverse effects* / Q000627:therapeutic use; D011358:Product Surveillance, Postmarketing; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration
D000969:Antinematodal Agents; D018942:Macrolides; C027837:moxidectin